https://www.progranulinnavigator.org https://www.progranulinnavigator.org/individuals-and-families https://www.progranulinnavigator.org/providers https://www.progranulinnavigator.org/resources https://www.progranulinnavigator.org/about-us https://www.progranulinnavigator.org/directory https://www.progranulinnavigator.org/contact-us https://www.progranulinnavigator.org/laura-mitic https://www.progranulinnavigator.org/alexandra-nicholson https://www.progranulinnavigator.org/rachel-acuna-narvaez https://www.progranulinnavigator.org/erynn-gordon https://www.progranulinnavigator.org/stay-in-the-know https://www.progranulinnavigator.org/disclaimer https://www.progranulinnavigator.org/privacy-policy https://www.progranulinnavigator.org/genetic-testing-screener https://www.progranulinnavigator.org/faq https://www.progranulinnavigator.org/resources/blog https://www.progranulinnavigator.org/resources/support-resources https://www.progranulinnavigator.org/resources/news https://www.progranulinnavigator.org/resources/faqs https://www.progranulinnavigator.org/resources/why-genetic-testng-and-clinical-trials-matter-for-ftd-grn-a-personal-story https://www.progranulinnavigator.org/resources/how-does-genetic-testing-intersect-with-grief https://www.progranulinnavigator.org/resources/presymptomatic-ftd-genetic-testing-guide https://www.progranulinnavigator.org/resources/personality-changes-psychiatric-dementia-ftd https://www.progranulinnavigator.org/resources/should-you-consider-an-experimental-clinical-trial-for-ftd-frontotemporal-degeneration https://www.progranulinnavigator.org/resources/what-is-frontotemporal-degeneration-a-guide-for-families https://www.progranulinnavigator.org/unsubscribe https://www.progranulinnavigator.org/resources/thinking-about-genetic-testing-heres-what-to-know-about-insurance https://www.progranulinnavigator.org/resources/when-the-diagnosis-finally-came-our-journey-with-frontotemporal-dementia https://www.progranulinnavigator.org/resources/should-i-get-genetic-testing https://www.progranulinnavigator.org/glossary https://www.progranulinnavigator.org/resources/genetic-testing-and-ftd-a-simple-guide-for-patients-and-families https://www.progranulinnavigator.org/resources/what-is-progranulin-understanding-its-role-in-grn-related-frontotemporal-degeneration https://www.progranulinnavigator.org/resources/you-got-your-genetic-test-results--now-what https://www.progranulinnavigator.org/resources/it-changes-lives-for-generations-why-clinical-trials-and-genetic-testing-matter-for-ftd https://www.progranulinnavigator.org/trials/a-phase-3-study-to-evaluate-efficacy-and-safety-of-al001-in-frontotemporal-dementia-infront-3 https://www.progranulinnavigator.org/trials/a-study-of-pbft02-in-patients-with-frontotemporal-dementia-and-progranulin-mutations-ftd-grn-uplift-d https://www.progranulinnavigator.org/trials/a-study-to-evaluate-the-safety-and-effect-of-avb-101-a-gene-therapy-product-in-subjects-with-a-genetic-subtype-of-frontotemporal-dementia-ftd-grn-aspire-ftd https://www.progranulinnavigator.org/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-dnl593-in-healthy-participants-and-participants-with-frontotemporal-dementia-ftd-grn https://www.progranulinnavigator.org/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ves001-in-healthy-participants-sort-in-1 https://www.progranulinnavigator.org/trials/phase-1-2-clinical-trial-of-ly3884963-in-patients-with-frontotemporal-dementia-with-progranulin-mutations-ftd-grn-proclaim